Federal Law: Prescriptions and Dispensing
About 18 of every 120 questions on each practice exam (Illinois MPJE, New York MPJE and Texas MPJE) come from this topic.
Sources checked
What to know
Federal controlled substance prescriptions must be dated and signed on the day issued, show the patient's full name and address and the prescriber's name, address and DEA number, and serve a legitimate medical purpose. Schedule II drugs need a signed paper or electronic prescription and are never refilled. A faxed C-II serves as the original only for LTCF residents, hospice patients (narcotics, noted as hospice) and narcotics compounded for infusion. An emergency phoned C-II order covers only the emergency period, needs a written follow-up marked "Authorization for Emergency Dispensing" within 7 days (or a report to DEA), and may not be relayed by an agent. C-II partial fills: 72 hours when stock is short, 30 days from writing when the patient or prescriber asks, 60 days for LTCF or terminally ill patients. C-III to V prescriptions allow 5 refills within 6 months; refill transfers are one-time, pharmacist to pharmacist, unless pharmacies share a real-time database. An unfilled electronic C-II to V prescription may be transferred once, electronically. C-II to IV labels carry the transfer warning; drugs need "Rx only"; Medication Guides accompany new and refill prescriptions. Oral prescription drugs need child-resistant packaging unless the prescriber or purchaser waives it. Pseudoephedrine sales are capped at 3.6 g daily, with a logbook. OTC C-V sales require a pharmacist, age 18 and a bound book. Orange Book A codes mean equivalent; interchangeable biologics may be substituted without the prescriber. 503A compounding is patient-specific.
Where it comes from
- 21 CFR 1306.03-1306.08
- 21 CFR 1306.11
- 21 CFR 1306.12
- 21 CFR 1306.13
- 21 CFR 1306.14
- 21 CFR 1306.21-1306.26
- 21 CFR 1306.07(f)
- 21 CFR 1311.102, 1311.115, 1311.170, 1311.200, 1311.305
- 21 CFR 290.5, 290.10
- 21 U.S.C. 829
- 21 U.S.C. 353(b)
- 21 CFR 201.66
- 21 CFR 208.1, 208.24, 208.26
- 21 CFR 310.501, 310.515
- 16 CFR 1700.14; 15 U.S.C. 1473
- 21 U.S.C. 830, 844; 21 CFR 1314.20-1314.30
- FDA Orange Book Preface
- 42 U.S.C. 262(i), (k)
- 21 U.S.C. 353a
- DEA Statement of Policy, 75 FR 61613 (2010)
Try a practice question
Under federal DEA rules, when must a prescription for a controlled substance be dated and signed?
- ABefore it is presented at any pharmacy for filling
- BOn the day the pharmacist first dispenses it
- COn the day the practitioner issues it
- DWithin 7 days after the practitioner issues it
Show the answer
On the day the practitioner issues it. DEA requires every controlled substance prescription to be dated as of, and signed on, the day it is issued. Postdating or later signing does not meet the rule.
21 CFR 1306.05(a)
Practice exams that test this topic
Not sure which exam you take? See Pharmacy Law Exam (MPJE) Requirements.